• Medication-assisted treatment is superior to placebo and counseling-only treatment for opioid use disorders.
• Buprenorphine-naloxone (BUP-NX) and extended-release naltrexone (XR-NTX) are two such medications, and they can be prescribed in any U.S. medical setting, making them key…

• Technology-assisted interventions for substance use disorders show great promise for providing access to high-quality, evidence-based interventions while reducing barriers such as cost, geographic distance from specialty care, and stigma.

Despite socioeconomic disparities…

• Social Exchange Theory suggests that heterosexual power inequities influence sexual negotiation.


• The Theory of Gender and Power adds that a history of abuse may increase the power differential and disempower women from advocating for their own best interests.

…

• Many patients are lost at each step along the HIV care cascade.
• The current standard-of-care pathway from screening to starting antiretroviral therapy (ART) in China involves multiple hospital visits, separate blood draws, and protracted waiting periods, resulting in substantial…

• Pear Therapeutics, producer of a number of digital therapeutic tools, announced this month that the FDA has approved their marketing of a smartphone-based tool call “reSET®” for the treatment of patients with substance use disorder (SUD).
• This is the first time the FDA has cleared…

• Authored by members of the Center for the Clinical Trials Network, in collaboration with the NIDA Intramural Research Program, this article reports on a clinical trial that found that adding clonidine to buprenorphine treatment for opioid dependence increased abstinence and decoupled stress…

• The Centers for Disease Control and Prevention (CDC) recently reported that cigarette smoking among adults in the U.S. has decreased from 20.9% in 2005 to 15.1% in 2015.

As smoking prevalence declines overall, smoking in subgroups becomes increasingly important in terms of…

• Post-traumatic stress disorder (PTSD) and substance use disorders frequently co-occur, and are associated with a host of complex clinical and public health challenges.
• Additionally, the detrimental effects of concurrent substance use disorders (SUD), for example, cocaine and…

• Integration of substance use disorder (SUD) services within primary care provides an opportunity to increase identification of SUD and improve access to treatment for patients.
• However, SUDs are typically under-detected in the primary care setting, and treatment is rarely actually…

• Cannabis use disorder (CUD) is a prevalent and impairing condition, impacting an estimated 1 in 11 adult users of cannabis, and established psychosocial treatments convey limited efficacy.
• In light of recent findings supporting the efficacy of N-acetylcysteine (NAC) for CUD in…